Toothpaste Abrasion Chart
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Gel-Syn™ Product Information Caution
GEL-SYN™ PRODUCT INFORMATION CAUTION: Federal law restricts this device to sale by or on the order of a physician (or properly licensed practitioner). CONTENT Each 1 mL of Gel-Syn contains: Sodium Hyaluronate: 8.4 mg Sodium Chloride: 8.5 mg Sodium Phosphate, Dibasic: 0.16 mg Sodium Phosphate, Monobasic: 0.045 mg Water for Injection: q.s. to 1.0 mL DESCRIPTION Gel-Syn is a sterile, buffered solution of highly purified sodium hyaluronate with a molecular weight of approximately 1100 kDa, obtained through fermentation of Streptococci of Lancefield groups A and C and chemically unmodified. INDICATION Gel-Syn is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). CONTRAINDICATIONS • Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. • Do not inject Gel-Syn into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site. WARNINGS • Do not concomitantly use disinfectants containing quaternary ammonium salts for skin preparation because sodium hyaluronate can precipitate in their presence. • Inject into the synovial space only. Do not inject by intravascular route. • Do not inject outside the synovial space or into the synovial tissue or capsule. An extra- articular injection of the product can cause local adverse events. PRECAUTIONS General • The safety and effectiveness of Gel-Syn in locations other than the knee, and for conditions other than osteoarthritis, have not been established. • Strict aseptic administration technique must be followed. -
Rectal Suppository & Enema Administration to Administration Unlicensed Assistive Personnel (UAP) Module/Skill Checklist
Delegation of Medication Rectal Suppository & Enema Administration to Administration Unlicensed Assistive Personnel (UAP) Module/Skill Checklist Objective At the completion of this module, the UAP should be able to administer rectal suppository & enema medications. NOTE: 1) The RN or LPN is permitted to delegate ONLY after application of all components of the NCBON Decision Tree for Delegation to UAP and after careful consideration that delegation is appropriate: a) for this client, b) with this acuity level, c) with this individual UAP’s knowledge and experience, and d) now (or in the time period being planned). 2) Successful completion of the “Infection Control” module by the UAP should be documented prior to instruction in medication administration by this or ANY route. Procedure for: SUPPOSITORY 1. Perform skills in General Medication Administration Checklist. 2. Provide privacy. Have client void before procedure. 3. Put on clean gloves. 4. Position the client on their left (preferred) side with the top leg bent slightly. 5. Remove the foil or wrapper from the suppository, if present. 6. Apply a small amount of lubricant to the suppository and your gloved index finger on your dominant hand – the hand holding the suppository. 7. Separate the buttocks with your gloved, non dominant hand. 8. Ask the client to breathe slowly and deeply through the mouth. 9. Place tip of suppository against anus and gently insert the suppository about 4- inches along the rectal wall. Avoid putting the suppository in stool. 10. After removing your finger, squeeze buttocks together for a few minutes to help client hold in the suppository for as long as possible. -
Church & Dwight Co., Inc
cd_2004_an_pdf_cov.qxd 5/3/05 5:16 PM Page 1 2004 CHURCH & DWIGHT CO., INC. ® Annual Report cd_2004_an_pdf_cov.qxd 5/3/05 5:16 PM Page 2 Financial Highlights Dollars in millions, except per share data 2004 2003 CHANGE SALES $1,462 $1,057 +38% INCOME FROM OPERATIONS 172 112 +54% NET INCOME 89 81 +10% NET INCOME PER SHARE - DILUTED 1.36 1.28 +6% DIVIDENDS PER SHARE 0.23 0.21 +10% Additional Information COMBINED SALES (1) (2) $1,702 $1,508 +13% ADJUSTED NET INCOME PER SHARE - DILUTED(1) (3) 1.66 1.33 +25% (1) These are non-GAAP (Generally Accepted Accounting Principles) measures of performance. See notes 2 and 3 for the reconciliations of the non-GAAP numbers to the most directly comparable GAAP financial measure. (2) Includes Armkel sales of $193 million and $411 million for 2004 and 2003, respectively, and Other Equity Affiliates sales of $56 million and $49 million for 2004 and 2003, respectively. Excludes intercompany sales of $9 million for both 2004 and 2003. Management believes this information is useful to investors because the businesses of the Company and its unconsolidated equity investees are managed on a combined basis, and management uses combined performance measures to analyze performance and develop financial objectives. Moreover, since the results of operations of the former Armkel business have been included in Church & Dwight's consolidated statement of income beginning on May 29, 2004, the information enhances comparability over the relevant period. (3) Excludes, in 2004, an accounting charge of $0.10 per share related to the acquisition of the 50% interest in Armkel that the Company did not previously own, as well as charges of $0.20 per share related to the early redemption of debt. -
Physical-Chemical Characteristics of Whitening Toothpaste and Evaluation of Its Effects on Enamel Roughness
Dental materials Physical-chemical characteristics of whitening toothpaste and evaluation of its effects on enamel roughness Sérgio Paulo Hilgenberg(a) Abstract: This in vitro study evaluated the physical-chemical characteris- (a) Shelon Cristina Souza Pinto tics of whitening toothpastes and their effect on bovine enamel after ap- Paulo Vitor Farago(b) Fábio André Santos(a) plication of a bleaching agent (16% carbamide peroxide). Physical-chem- Denise Stadler Wambier(a) ical analysis was made considering mass loss by desiccation, ash content and pH of the toothpastes. Thirty bovine dental enamel fragments were prepared for roughness measurements. The samples were subjected to (a) Department of Dentistry, School of Dentistry, Ponta Grossa State University, bleaching treatments and simulated brushing: G1. Sorriso Dentes Brancos Ponta Grossa, PR, Brazil. (Conventional toothpaste), G2. Close-UP Whitening (Whitening tooth- (b) Department of Pharmacy, School of paste), and G3. Sensodyne Branqueador (Whitening toothpaste). The av- Dentistry, Ponta Grossa State University, erage roughness (Ra) was evaluated prior to the bleaching treatment and Ponta Grossa, PR, Brazil. after brushing. The results revealed differences in the physical-chemical characteristics of the toothpastes (p < 0.0001). The final Ra had higher values (p < 0.05) following the procedures. The mean of the Ra did not show significant differences, considering toothpaste groups and bleach- ing treatment. Interaction (toothpaste and bleaching treatment) showed significant difference -
An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: a Review
Muthadi Radhika Reddy /J. Pharm. Sci. & Res. Vol. 12(7), 2020, 925-940 An Introduction to Fast Dissolving Oral Thin Film Drug Delivery Systems: A Review Muthadi Radhika Reddy1* 1School of pharmacy, Gurunanak Institute of Technical Campus, Hyderabad, Telangana, India and Department of Pharmacy, Gandhi Institute of Technology and Management University, Vizag, Andhra Pradesh, India INTRODUCTION 2. Useful in situations where rapid onset of action Fast dissolving drug delivery systems were first developed required such as in motion sickness, allergic attack, in the late 1970s as an alternative to conventional dosage coughing or asthma forms. These systems consist of solid dosage forms that 3. Has wide range of applications in pharmaceuticals, Rx disintegrate and dissolve quickly in the oral cavity without Prescriptions and OTC medications for treating pain, the need of water [1]. Fast dissolving drug delivery cough/cold, gastro-esophageal reflux disease,erectile systems include orally disintegrating tablets (ODTs) and dysfunction, sleep disorders, dietary supplements, etc oral thin films (OTFs). The Centre for Drug Evaluation [4] and Research (CDER) defines ODTs as,“a solid dosage 4. No water is required for the administration and hence form containing medicinal substances which disintegrates suitable during travelling rapidly, usually within a matter of seconds, when placed 5. Some drugs are absorbed from the mouth, pharynx upon the tongue” [2]. USFDA defines OTFs as, “a thin, and esophagus as the saliva passes down into the flexible, non-friable polymeric film strip containing one or stomach, enhancing bioavailability of drugs more dispersed active pharmaceutical ingredients which is 6. May offer improved bioavailability for poorly water intended to be placed on the tongue for rapid soluble drugs by offering large surface area as it disintegration or dissolution in the saliva prior to disintegrates and dissolves rapidly swallowing for delivery into the gastrointestinal tract” [3]. -
Logistics Efficiency Development in Distribution and Damage Control”
Internship report On “Logistics Efficiency Development in Distribution and Damage Control” Prepared For: Ms. Mahtab Faruqui Senior Lecturer BRAC Business School BRAC University. Prepared By: Irfan Rafique ID: 08104001 BRAC Business School BRAC University. Date: 23rd January, 2012. Letter of transmittal January 23rd, 2012 Ms. Mahtab Faruqui Senior Lecturer BRAC Business School BRAC University. Subject: Submission of internship report. Dear Madam, I would like to take the opportunity to thank you for the guidance and support you have provided me during the course of this report. I also want to express deep gratuities to Mr. Rezwan Hamid, Territory manager, Tejgoan territory for his cooperation and supervision. In this report this report I tried my level best to provide authentic information. I also tried to reflect my experience driven learning and findings. I request you to excuse me for any mistake despite my best effort. I also appreciate if you enlighten me with your thoughts and views regarding the report. Also, if you wish to enquire about any aspect of my report, I would gladly answer your questions. Yours Sincerely, Irfan Rafique ID: 08104001 BRAC Business School BRAC University ACKNOWLEDGEMENT Prosperous conclusion of any course requires support from various personal and I was fortunate to have support, direction and supervision in every aspect from my teacher, Unilever officials and friends. I would also like to express my cordial thanks and gratitude to my supervisor of internship program Ms. Mahtab Faruqui, senior lecturer for farm encouragement as well as guidance in preparing this report. I acknowledge my gratitude to Mr. Rezwan Hamid for his guidance, cooperation and help. -
Acrylamide Polymerization — a Practical Approach
electrophoresis tech note 1156 Acrylamide Polymerization — A Practical Approach Paul Menter, Bio-Rad Laboratories, 2000 Alfred Nobel Drive, Polyacrylamide Gel Polymerization Hercules, CA 94547 USA AcrylamideBis Polyacrylamide Introduction The unparalleled resolution and flexibility possible with CH2 CH + CH2 CH CH2 CH CH2 CH CH2 CH polyacrylamide gel electrophoresis (PAGE) has led to its CO CO CO CO CO widespread use for the separation of proteins and nucleic NH2 NH NH2 NH2 NH acids. Gel porosity can be varied over a wide range to meet CH2 CH2 specific separation requirements. Electrophoresis gels and NH NH NH NH buffers can be chosen to provide separation on the basis of CO 2 2 CO CO C O charge, size, or a combination of charge and size. CH2 CH CH2 CH CH2 CH CH2 CH The key to mastering this powerful technique lies in the polymerization process itself. By understanding the important Purity of Gel-Forming Reagents parameters, and following a few simple guidelines, the novice Acrylamide can become proficient and the experienced user can optimize Gel-forming reagents include the monomers, acrylamide and bis, separations even further. as well as the initiators, usually ammonium persulfate and TEMED or, occasionally, riboflavin and TEMED. On a molar This bulletin takes a practical approach to the preparation of basis, acrylamide is by far the most abundant component in the polyacrylamide gels. Its purpose is to provide the information monomer solution. As a result, acrylamide may be the primary required to achieve reproducible, controllable polymerization. source of interfering contaminants (Dirksen and Chrambach For those users interested only in the “bare essentials,” the 1972). -
Guidelines for the Use of Fluorides
Guidelines for the Use of Fluorides the Use Guidelines for Guidelines for the Use of Fluorides September 2009 www.nzgg.org.nz www.moh.govt.nz Guidelines for the Use of Fluorides � © Ministry of Health 2009 Published by: Ministry of Health PO Box 5013, Wellington ISBN (Print): 978-0-478-33930-7 ISBN (Online): 978-0-478-31972-9 HP4952 Copyright The copyright owner of this publication is the Ministry of Health, which is part of the New Zealand Crown. Content may be reproduced in any number of copies and in any format or medium provided that a copyright acknowledgement to the New Zealand Ministry of Health is included and the content is neither changed, sold, nor used to promote or endorse any product or service, or used in any inappropriate or misleading context. For a full copyright statement, go to www.moh.govt.nz/copyright Funding and independence This guideline was funded by the Ministry of Health. The development of the guideline was researched and written by New Zealand Guidelines Group (NZGG) employees or contractors. The searching for the evidence and the review of the evidence were independent of the Ministry of Health. Recommendation formulation was completed by an independent expert advisory group, and their recommendations have not been altered by the Ministry. Statement of intent NZGG produces evidence-based best practice guidelines to help health care practitioners, policy-makers and consumers make decisions about health care in specific clinical circumstances. This document is not a fully evidence-based guideline in that the evidence was not systematically critically appraised and the recommendations are not graded to show the extent to which they are supported by the evidence. -
AP-24® Anti-Plaque Fluoride Toothpaste Whitening Fluoride Toothpaste
NU SKIN® PRODUCT INFORMATION PAGE AP-24® Anti-Plaque Fluoride Toothpaste Whitening Fluoride Toothpaste System Overview The AP-24® Oral Care System is a revolutionary, scientifically advanced line of oral health care products that helps provide anti- plaque protection. AP-24® Anti-Plaque Fluoride Toothpaste Frequently Asked Questions What is the RDA of AP-24® Anti-Plaque Fluoride Toothpaste? Product Overview RDA (Radioactive Dentin Abrasion) is the scale used to measure Prevents plaque buildup. This cavity-fighting formula features a relative abrasivity of toothpastes. This scale starts at 0 and is open- patented plaque-fighting agent that helps remove plaque and debris ended. It’s generally agreed that any product that falls below 250 as you brush. The gentle formula freshens breath with vanilla mint is considered safe for everyday use. The RDA value of AP-24® and leaves a clean, fresh-mouth feeling that lasts all day. Anti-Plaque Fluoride Toothpaste is between 70 and 80, which is considered very mild. 1 Benefits • Removes plaque during brushing. Which ingredient helps remove plaque from the teeth? • Leaves a clean, just-brushed feeling that lasts. The abrasive system used in this AP-24® toothpaste consists of • Gentle to teeth and mild to gums. dicalcium phosphate. • Helps loosen and remove debris. Are AP-24® products ADA approved? Key Ingredients AP-24® products are not ADA (American Dental Association) • AP-24®—a patented plaque-fighting agent of medical-grade approved. The ADA is a private, nongovernmental organization that dimethicone and surfactants. AP-24® is a long chain that can charges a yearly fee for use of its name. -
Corporate Venturing: the Origins of Unilever's Pregnancy Test
This article was downloaded by: [Harvard College] On: 07 January 2013, At: 13:10 Publisher: Routledge Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Business History Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/fbsh20 Corporate venturing: the origins of Unilever's pregnancy test Geoffrey Jones a & Alison Kraft b a Harvard Business School b University of Nottingham Version of record first published: 04 Jun 2010. To cite this article: Geoffrey Jones & Alison Kraft (2004): Corporate venturing: the origins of Unilever's pregnancy test, Business History, 46:1, 100-122 To link to this article: http://dx.doi.org/10.1080/00076790412331270139 PLEASE SCROLL DOWN FOR ARTICLE Full terms and conditions of use: http://www.tandfonline.com/page/terms-and-conditions This article may be used for research, teaching, and private study purposes. Any substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing, systematic supply, or distribution in any form to anyone is expressly forbidden. The publisher does not give any warranty express or implied or make any representation that the contents will be complete or accurate or up to date. The accuracy of any instructions, formulae, and drug doses should be independently verified with primary sources. The publisher shall not be liable for any loss, actions, claims, proceedings, demand, or costs or damages whatsoever or howsoever caused arising directly or indirectly in connection with or arising out of the use of this material. 461bh05.qxd 28/11/03 08:23 Page 100 Corporate Venturing: The Origins of Unilever’s Pregnancy Test GEOFFREY JONES Harvard Business School ALISON KRAFT University of Nottingham The relative ability of different sizes of firm and organisational designs to develop and sustain dynamic capabilities in innovation and create new businesses remains a matter of contention. -
Innovation Is P&G's Life Blood
Innovation is P&G Innovations P&G’s Life Blood It is the company’s core growth strategy and growth engine. It is also one of the company’s five core strengths, outlined for focus and investment. Innovation translates consumer desires into new products. P&G’s aim is to set the pace for innovation and the benchmark for innovation success in the industry. In 2008, P&G had five of the top 10 new product launches in the US, and 10 of the top 25, according to IRI Pacesetters, a report released by Information Resources, Inc., capturing the most successful new CPG products, as measured by sales, over the past year. Over the past 14 years, P&G has had 114 top 25 Pacesetters—more than our six largest competitors combined. PRODUCT INNOVATION FIRSTS 1879 IVORY First white soap equal in quality to imported castiles 1901 GILLETTE RAZOR First disposable razor, with a double-edge blade, offers alternative to the straight edge; Gillette joins P&G in 2005 1911 CRISCO First all-vegetable shortening 1933 DREFT First synthetic household detergent 1934 DRENE First detergent shampoo 1946 TIDE First heavy-duty The “washday miracle” is introduced laundry detergent with a new, superior cleaning formula. Tide makes laundry easier and less time-consuming. Its popularity with consumers makes Tide the country’s leading laundry product by 1949. 1955 CREST First toothpaste proven A breakthrough-product, using effective in the prevention fluoride to protect against tooth of tooth decay; and the first decay, the second most prevalent to be recognized effective disease at the time. -
Toothpaste Abrasivenss Chart 2016 Article.Pages
Chart from Published Article on Toothpaste Abrasiveness 2016 John R Droter DDS Rath, S. K., Sharma, V., & Pratap, C. B. (2016). Abrasivity of dentrifices: An update. SRM Journal of Research …. http://doi.org/10.4103/0976-433X.182662 Toothpaste Name RDA- Relative Dentin Abrasiveness Toothpaste Name RDA- Relative Dentin Abrasiveness Toothbrush with plain water 4 Nature’s Gate 87 Plain baking soda 7 Mentadent Advanced Breath Freshening 88 Arm and Hammer Dental Care Tooth Powder 8 Aquafresh Sensitive 91 Weleda Salt Toothpaste 15 Tom’s of Maine 93-100 Elmex Sensitive Plus 30 Rembrandt Plus 94 Weleda Plant Tooth Gel 30 Oxyfresh with Fluoride 95 Sensodyne ProNamel - Isoactive - Daily Protection 32±15% Aim Cavity Protection Toothpaste 96 Sensodyne ProNamel - Mint Essence 37±15% Oxyfresh Powder 97 Sensodyne ProNamel - Fresh Wave 37±15% Arm and Hammer Advanced White Brilliant Sparkle Gel Weleda Children’s Tooth Gel 40 100 ARM and Hammer PeroxiCare Toothpaste 42 Close-Up Cinnamon Red Gel with Mouthwash 100 Arm and Hammer Advance White Baking Soda and Peroxide Natural White 101 42 SENSODYNE ProNamel Iso-active Gentle Whitening Sensodyne Iso-active - Multi Action 44±15% 100±15% Squiggle Enamel Saver 45-55 Crest Whitening Expressions (liquid gel) 105 Weleda Calendula Toothpaste 45 Colgate Platinum 106 Weleda Pink Toothpaste with Ratanhia 45 Crest Baking Soda and Peroxide Whitening 107 Oxyfresh 45 Crest Kid’s 108 Arm and Hammer Dental Care Advanced Cleaning Toothpaste Crest Cavity Protection 108 49 Crest Advanced Cleaning 109 Tom’s of Maine Sensitive